AngioDynamics
ANGO
138 hedge funds and large institutions have $428M invested in AngioDynamics in 2020 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 52 increasing their positions, 43 reducing their positions, and 25 closing their positions.
213% more call options, than puts
Call options by funds: $1.06M | Put options by funds: $340K
21% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 43
14% more capital invested
Capital invested by funds: $374M → $428M (+$53.9M)
2.34% less ownership
Funds ownership: 97.63% → 95.29% (-2.3%)
5% less funds holding
Funds holding: 146 → 138 (-8)
28% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PGM
Parian Global Management
Pound Ridge,
New York
|
+$3.29M |
| 2 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$2.47M |
| 3 |
Millennium Management
New York
|
+$2.42M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$2.28M |
| 5 |
LAM
Lapides Asset Management
Greenwich,
Connecticut
|
+$2.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tributary Capital Management
Omaha,
Nebraska
|
-$6.96M |
| 2 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$4.52M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$4.18M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$3.36M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.26M |
ANGO Hedge Fund Activity: Q3 2020 in Review
138 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q3 2020, worth a combined $428M — up 14% from $374M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of ANGO and 18 opened new positions — a net loss of 7 holders — while 43 trimmed existing stakes and 52 added.
The largest buyer was Parian Global Management, opening a new position worth an estimated $3.29M. The largest seller was Tributary Capital Management, exiting entirely with an estimated $6.96M sold.
- 138 institutional investors held AngioDynamics (ANGO) as of Q3 2020, down from 146 in Q2 2020.
- Funds reported $428M of AngioDynamics stock for Q3 2020, up 14% quarter-over-quarter.
- 18 funds opened new AngioDynamics positions in Q3 2020 and 25 closed out, a net change of -7 holders.
- The largest AngioDynamics buyer in Q3 2020 was Parian Global Management, an estimated $3.29M added.
- The largest AngioDynamics seller in Q3 2020 was Tributary Capital Management, an estimated $6.96M sold.
Based on aggregated 13F filings for Q3 2020.